GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 325 filers reported holding GUARDANT HEALTH INC in Q2 2020. The put-call ratio across all filers is 2.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12 | -20.0% | 412 | 0.0% | 0.00% | – |
| Q2 2023 | $15 | +50.0% | 412 | 0.0% | 0.00% | – |
| Q1 2023 | $10 | -9.1% | 412 | 0.0% | 0.00% | – |
| Q4 2022 | $11 | -99.9% | 412 | +8.4% | 0.00% | – |
| Q3 2022 | $20,000 | +33.3% | 380 | 0.0% | 0.00% | – |
| Q2 2022 | $15,000 | -25.0% | 380 | +27.9% | 0.00% | – |
| Q1 2022 | $20,000 | -33.3% | 297 | 0.0% | 0.00% | – |
| Q4 2021 | $30,000 | -30.2% | 297 | -14.4% | 0.00% | – |
| Q3 2021 | $43,000 | +72.0% | 347 | +74.4% | 0.00% | – |
| Q2 2021 | $25,000 | -92.3% | 199 | -90.6% | 0.00% | -100.0% |
| Q1 2021 | $323,000 | +1245.8% | 2,118 | +1026.6% | 0.00% | – |
| Q4 2020 | $24,000 | -60.0% | 188 | -65.1% | 0.00% | -100.0% |
| Q3 2020 | $60,000 | +62.2% | 539 | +1.7% | 0.00% | 0.0% |
| Q2 2020 | $37,000 | 0.0% | 530 | 0.0% | 0.00% | – |
| Q1 2020 | $37,000 | -9.8% | 530 | 0.0% | 0.00% | – |
| Q4 2019 | $41,000 | – | 530 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |